Current applications and future prospects of nanotechnology in cancer immunotherapy

【Author】

Sen Yan;Peng Zhao;Tingting Yu;Ning Gu;State Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science &Medical Engineering, Southeast University;Collaborative Innovation Center of Suzhou Nano Science and Technology;Department of Medical Genetics, School of Basic Medical Science, Nanjing Medical University;Jiangsu Key Laboratory of Xenotransplantation, Nanjing Medical University;

【Institution】

State Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science &Medical Engineering, Southeast University;Collaborative Innovation Center of Suzhou Nano Science and Technology;Department of Medical Genetics, School of Basic Medical Science, Nanjing Medical University;Jiangsu Key Laboratory of Xenotransplantation, Nanjing Medical University;

【Abstract】

Cancer immunotherapy is an artificial stimulation of the immune system to recognize cancer cells and activate specific immune cells to target and attack cancer cells.In clinical trials, immunotherapy has recently shown impressive results in the treatment of multiple cancers.Thus, cancer immunotherapy has gained a lot of attention for its unique advantages and promising future.With extensive research on cancer immunotherapy, its safety and effectiveness has gradually been revealed.However, it is still a huge challenge to expand and drive this therapy while maintaining low toxicity, high specificity, and long-lasting efficacy.As a unique technology, nanotechnology has been applied in many fields, the advantages of which will promote the development of cancer immunotherapies.Researchers have tried to apply nanomaterials to cancer immunotherapy due to their advantageous properties,such as large specific surface areas, effective drug delivery, and controlled surface chemistry, to improve treatment efficacy.Here,we briefly introduce the current applications of nanomaterials in cancer immunotherapy, including adoptive cell therapy(ACT),therapeutic cancer vaccines, and monoclonal antibodies, and throw light on future directions of nanotechnology-based cancer immunotherapy.

【Keywords】

Cancer immunotherapy;;nanotechnology;;therapeutic cancer vaccine;;monoclonal antibody

References

To explore the background and basis of the node document

Springer Journals Database

Total: 52 articles

  • [1] Satoko Matsueda;David Y Graham;Cancer Vaccine Development Division,Research Center for Innovative Cancer Therapy,Kurume University,Kurume,Fukuoka 830-0011,Japan;Michael E DeBakey VA Medical Center,Baylor College of Medicine,Houston,TX 77030,United States;, Immunotherapy in gastric cancer, World Journal of Gastroenterology,
  • [2] Kevin Letchford;;Helen Burt, A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes, European Journal of Pharmaceutics and Biopharmaceutics,
  • [3] Louis M Weiner;;Madhav V Dhodapkar;;Soldano Ferrone, Monoclonal antibodies for cancer immunotherapy, The Lancet,
  • [4] Samar Hamdy;;Ommoleila Molavi;;Zengshuan Ma;;Azita Haddadi;;Aws Alshamsan;;Zahra Gobti;;Sara Elhasi;;John Samuel;;Afsaneh Lavasanifar, Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8 + T cell-mediated anti-tumor immunity, Vaccine,

More>>

Similar documents

Documents that have the similar content to the node document

Springer Journals Database

Total: 32 articles

  • [1] Lawrence LESSNER, DEA-based anti-HIV immunotherapy model, Progress in Natural Science, 2004 (09)
  • [2] Systemic chemo-immunotherapy for advanced-stage hepatocellular carcinoma, World Journal of Gastroenterology, 2005 (16)
  • [3] Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients, World Journal of Gastroenterology, 2010 (48)
  • [4] A Brief Account of Professor Wu Mengchao, Journal of Medical Colleges of PLA, 1998 (01)

More>>